Bluebird Bio Inc (BLUE)

06:29 AM

Will earnings trigger a reversal in bluebird bio Inc.Quarterly Profit Report & Weekly Watchlist for Consistent Profits - newser.com

06:29 AM

04:24 AM

Will bluebird bio Inc. see short term momentumWeekly Profit Analysis & Breakout Confirmation Alerts - newser.com

04:24 AM

Oct 18, 2025

Should I hold or sell bluebird bio Inc. stock in 20252025 Volatility Report & Target Return Focused Stock Picks - nchmf.gov.vn

Oct 18, 2025

Oct 18, 2025

What Wall Street predicts for bluebird bio Inc. stock priceAnalyst Upgrade & AI Based Buy and Sell Signals - newser.com

Oct 18, 2025

Oct 17, 2025

Is bluebird bio Inc. stock a smart buy before Fed meetingJuly 2025 Market Mood & Detailed Earnings Play Strategies - nchmf.gov.vn

Oct 17, 2025

Oct 16, 2025

What technical signals suggest for bluebird bio Inc. stockJuly 2025 Retail & Daily Chart Pattern Signals - newser.com

Oct 16, 2025

Oct 16, 2025

Lobbying Update: $60,000 of GENETIX BIOTHERAPEUTICS INC. (FORMERLY BLUEBIRD BIO INC.) lobbying was just disclosed - Quiver Quantitative

Oct 16, 2025

Oct 15, 2025

Is bluebird bio Inc. stock supported by strong fundamentalsWeekly Risk Report & Entry Point Confirmation Signals - newser.com

Oct 15, 2025

Oct 14, 2025

Car T Cell Therapy For Multiple Myeloma Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Bluebird bio, Cellectis SA, Caribou Biosciences, Luminary - Barchart.com

Oct 14, 2025

Oct 14, 2025

United States Adrenoleukodystrophy Treatment Market - openPR.com

Oct 14, 2025

Oct 13, 2025

Pattern recognition hints at bluebird bio Inc. upsideMarket Sentiment Summary & Daily Price Action Insights - newser.com

Oct 13, 2025

Oct 11, 2025

The commercial real estate media source. - NEREJ

Oct 11, 2025

Oct 10, 2025

Regeneron backs bluebird with $100 mn, jointly work on cancer therapies - Entrepreneur India

Oct 10, 2025

Oct 10, 2025

Has bluebird bio Inc. formed a bullish divergenceJuly 2025 Short Interest & Fast Entry and Exit Trade Plans - newser.com

Oct 10, 2025

Oct 10, 2025

Analyzing recovery setups for bluebird bio Inc. investorsWeekly Trade Analysis & High Accuracy Swing Entry Alerts - newser.com

Oct 10, 2025

Oct 09, 2025

News impact scoring models applied to bluebird bio Inc.Market Sentiment Summary & Technical Entry and Exit Tips - newser.com

Oct 09, 2025

Oct 09, 2025

Will bluebird bio Inc. benefit from macro trendsWeekly Trade Report & Technical Confirmation Trade Alerts - newser.com

Oct 09, 2025

Oct 06, 2025

Will bluebird bio Inc. bounce back from current supportDay Trade & Low Risk Investment Opportunities - newser.com

Oct 06, 2025

Oct 05, 2025

Is bluebird bio Inc a good long term investmentRisk Management Strategies & Free Explosive Wealth Accumulation - earlytimes.in

Oct 05, 2025

Oct 05, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 28, 2024 in bluebird bio LawsuitBLUE - MarketScreener

Oct 05, 2025

Oct 05, 2025

Chart based analysis of bluebird bio Inc. trends2025 Sector Review & Low Risk High Reward Ideas - newser.com

Oct 05, 2025

Oct 03, 2025

Is bluebird bio Inc. showing signs of accumulationForecast Cut & Short-Term Trading Alerts - newser.com

Oct 03, 2025

Oct 01, 2025

Former bluebird CEO picked to lead Inventiva - biocentury.com

Oct 01, 2025

Sep 30, 2025

What’s the recovery path for long term holders of bluebird bio Inc.Weekly Market Report & Low Volatility Stock Recommendations - newser.com

Sep 30, 2025

Sep 30, 2025

Gene Therapy for Rare Disease Market to Reach US$ 24.54 Bn by 2033, - openPR.com

Sep 30, 2025